Spyre Therapeutics
SYRE
SYRE
77 hedge funds and large institutions have $137M invested in Spyre Therapeutics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
+6
Holders Change %
+8.45%
% of All Funds
1.68%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
16
Increased
35
Reduced
9
Closed
8
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K
Top Buyers
| 1 |
BlackRock
New York
|
+$2.5M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$1.94M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.37M |
| 4 |
AG
Artal Group
Luxembourg
|
+$1.16M |
| 5 |
State Street
Boston,
Massachusetts
|
+$954K |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$6.25M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$5.4M |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$2.19M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$611K |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$179K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Daiwa Securities Group
Tokyo,
Japan
| $1K | – | – | – |
|
|
RBC
77
Roble Belko & Company
Sewickley,
Pennsylvania
| $1K | +$1K | +4 | New |
|
|
78
Jennison Associates
New York
| – | -$6.25M | -31,044 | Closed |
|
|
CH
79
CVI Holdings
Wilmington,
Delaware
| – | -$2.19M | -10,862 | Closed |
|
|
MWNA
80
Marshall Wace North America
New York
| – | -$179K | -892 | Closed |
|
|
WG
81
Winton Group
London,
United Kingdom
| – | -$96K | -479 | Closed |
|
|
PPA
82
Parametric Portfolio Associates
Seattle,
Washington
| – | -$91K | -450 | Closed |
|
|
ECM
83
ExodusPoint Capital Management
New York
| – | -$87K | -430 | Closed |
|
84
Acadian Asset Management
Boston,
Massachusetts
| – | -$69K | -343 | Closed |
|
|
DWA
85
Dorsey Wright & Associates
Pasadena,
California
| – | -$7K | -33 | Closed |
|